CUSIP: 03940C100 | NYSE | Healthcare · Biotechnology | Mid Cap | 488 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Holder | Shares | % of Class | Change | Event Date | vs 13F |
|---|---|---|---|---|---|
| 13G/AParadigm BioCapital Advisors LP | 0 | 0.0% | No shares held | Jun 30, 2026 | No 13F filer matched |
| 13D/AGilead Sciences, Inc. | 100 | 100.0% | −6,720,703 | Apr 28, 2026 | 28d ahead of 13F (6,720,803 sh) · −6,720,703 |
| 13D/ANew Enterprise Associates 15, L.P. | 0 | 0.0% | Fell below 5% | Apr 28, 2026 | No 13F filer matched |
| 13D/ARami Elghandour | 0 | 0.0% | Fell below 5% | Apr 28, 2026 | No 13F filer matched |
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 30,000 | $3.4K | 0.0% | Core | Low | Frankfurt, Hong Kong | 2026-08-05 | |
| 13 | $1.5K | 0.0% | Growth | Low | Tampa, FL | 2026-07-20 |